Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02535949 · ClinicalTrials.gov registry record · Phase 2
Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury
A Phase 2 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT02535949 is a Phase 2 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 150 participants.
The verdict
NCT02535949, a Phase 2 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of TXA on the immune system, its pharmacokinetics, as well as safety and efficacy in severely injured trauma patients.
Interventions
- OTHER Placebo
- DRUG Tranexamic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-07-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02535949
The ClinicalTrials.gov registry entry for NCT02535949 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02535949 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02535949 about?
NCT02535949 is a clinical study titled "Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury". The purpose of this study is to evaluate the effects of TXA on the immune system, its pharmacokinetics, as well as safety and efficacy in severely injured trauma patients.
What is the current status of trial NCT02535949?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2016-02. Estimated completion is 2017-07-07.
What interventions are being tested in trial NCT02535949?
The interventions under investigation include: Placebo (OTHER), Tranexamic Acid (DRUG).
Who is sponsoring clinical trial NCT02535949?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.